226 related articles for article (PubMed ID: 11912516)
1. Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.
Adachi Y; Matsubara S; Muramatsu T; Curiel DT; Reynolds PN
J Pediatr Surg; 2002 Apr; 37(4):588-92. PubMed ID: 11912516
[TBL] [Abstract][Full Text] [Related]
2. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
[TBL] [Abstract][Full Text] [Related]
3. Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells.
Miyauchi M; Yoshida Y; Tada Y; Narita M; Maeda T; Bahar R; Kadomatsu K; Muramatsu T; Matsubara S; Nakagawara A; Sakiyama S; Tagawa M
Int J Cancer; 2001 Mar; 91(5):723-7. PubMed ID: 11267987
[TBL] [Abstract][Full Text] [Related]
4. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma.
Wesseling JG; Yamamoto M; Adachi Y; Bosma PJ; van Wijland M; Blackwell JL; Li H; Reynolds PN; Dmitriev I; Vickers SM; Huibregtse K; Curiel DT
Cancer Gene Ther; 2001 Dec; 8(12):990-6. PubMed ID: 11781662
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
8. INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.
Wang HW; Breslin MB; Chen C; Akerstrom V; Zhong Q; Lan MS
Hum Gene Ther; 2009 Nov; 20(11):1308-18. PubMed ID: 19604042
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
11. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
[TBL] [Abstract][Full Text] [Related]
12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
13. [Antitumoral effect of HSV-tk suicide gene associated with ganciclovir in an experimental model of head and neck epidermoid carcinoma].
Boleas Aguirre MS; Fernández González S; Gallego Madrid MA; García-Tapia Urrutia R
Acta Otorrinolaringol Esp; 2002; 53(7):448-54. PubMed ID: 12487066
[TBL] [Abstract][Full Text] [Related]
14. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
[TBL] [Abstract][Full Text] [Related]
15. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
16. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B
Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Zhang R; Straus FH; DeGroot LJ
Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
[TBL] [Abstract][Full Text] [Related]
18. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
19. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter.
Vandier D; Rixe O; Besnard F; Kim M; Rikiyama T; Goldsmith M; Brenner M; Gouyette A; Cowan KH
Cancer Gene Ther; 2000 Aug; 7(8):1120-6. PubMed ID: 10975672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
